Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis
Armin Bayati, Rahul Kumar, Vincent Francis, et al.
Journal of Biological Chemistry (2021) Vol. 296, pp. 100306-100306
Open Access | Times Cited: 431

Showing 1-25 of 431 citing articles:

Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2532
Innate immunity: the first line of defense against SARS-CoV-2
Michael Diamond, Thirumala‐Devi Kanneganti
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 165-176
Open Access | Times Cited: 508
SARS-CoV-2 Omicron variant: recent progress and future perspectives
Yao Fan, Xiang Li, Lei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 484
Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
Yanjia Chen, Xiaoyu Zhao, Hao Zhou, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 189-199
Open Access | Times Cited: 284
Cell entry by SARS-CoV-2
Ruchao Peng, Lian-Ao Wu, Qingling Wang, et al.
Trends in Biochemical Sciences (2021) Vol. 46, Iss. 10, pp. 848-860
Open Access | Times Cited: 150
SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming
Chien-Ting Wu, Peter V. Lidsky, Yinghong Xiao, et al.
Cell (2022) Vol. 186, Iss. 1, pp. 112-130.e20
Open Access | Times Cited: 144
The role of high cholesterol in age-related COVID19 lethality
Hao Wang, Zixuan Yuan, Mahmud Arif Pavel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 140
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity
Rachid Essalmani, Jaspreet Jain, Delia Susan‐Resiga, et al.
Journal of Virology (2022) Vol. 96, Iss. 8
Open Access | Times Cited: 135
Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention
Ekta Shirbhate, Jaiprakash Pandey, Vijay K. Patel, et al.
Pharmacological Reports (2021) Vol. 73, Iss. 6, pp. 1539-1550
Open Access | Times Cited: 112
mRNA vaccines for COVID-19 and diverse diseases
Abid Hussain, Haiyin Yang, Jun Zhang, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 314-333
Open Access | Times Cited: 85
ACE2-Independent Alternative Receptors for SARS-CoV-2
Suhyeon Lim, Monica Zhang, Theresa L. Chang
Viruses (2022) Vol. 14, Iss. 11, pp. 2535-2535
Open Access | Times Cited: 73
Lipid Metabolism Modulation during SARS-CoV-2 Infection: A Spotlight on Extracellular Vesicles and Therapeutic Prospects
Heloísa D’Ávila, Claudia Natércia Rocha Lima, Pollianne Garbero Rampinelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 640-640
Open Access | Times Cited: 20
SARS-CoV-2 immunity in animal models
Chen Zhao, Yaochang Yuan, Qing‐Tao Hu, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 2, pp. 119-133
Open Access | Times Cited: 18
A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19
Amit S. Lokhande, Padma V. Devarajan
European Journal of Pharmacology (2020) Vol. 891, pp. 173748-173748
Open Access | Times Cited: 102
Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking
Pooyan Makvandi, Meiling Chen, Rossella Sartorius, et al.
Nano Today (2021) Vol. 40, pp. 101279-101279
Open Access | Times Cited: 98
COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development
Ramandeep Singh, Alisha Kang, Xiang‐Qian Luo, et al.
The FASEB Journal (2021) Vol. 35, Iss. 3
Open Access | Times Cited: 95
Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry
Selvin Noé Palacios-Rápalo, Luis Adrián De Jesús‐González, Carlos Daniel Cordero‐Rivera, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 89
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
Xiaonan Liu, Sini Huuskonen, Tuomo Laitinen, et al.
Molecular Systems Biology (2021) Vol. 17, Iss. 11
Open Access | Times Cited: 87
Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms
Anton Johansson, Mohamed S. Mohamed, Thiago C. Moulin, et al.
Journal of Neuroimmunology (2021) Vol. 358, pp. 577658-577658
Open Access | Times Cited: 72
Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19
Qingqin Tan, Lingjie He, Xiaojun Meng, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 68
Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates
Liliana Rodrigues, Renata Bento Cunha, Tatiana Vassilevskaia, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2723-2723
Open Access | Times Cited: 67
Coronavirus entry: how we arrived at SARS-CoV-2
Gary R. Whittaker, Susan Daniel, Jean K. Millet
Current Opinion in Virology (2021) Vol. 47, pp. 113-120
Open Access | Times Cited: 65
Integrin activation is an essential component of SARS-CoV-2 infection
Peter C. Simons, Derek A. Rinaldi, Virginie Bondu, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 63
Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response
Elisa Pesce, Nicola Manfrini, Chiara Cordiglieri, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 63
Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors
Chaitra Prabhakara, Rashmi Godbole, Parijat Sil, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 7, pp. e1009706-e1009706
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top